HOLX vs. PFE
Compare and contrast key facts about Hologic, Inc. (HOLX) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HOLX or PFE.
Correlation
The correlation between HOLX and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
HOLX vs. PFE - Performance Comparison
Loading data...
Key characteristics
HOLX:
-1.08
PFE:
-0.66
HOLX:
-1.40
PFE:
-0.64
HOLX:
0.81
PFE:
0.93
HOLX:
-0.64
PFE:
-0.22
HOLX:
-1.66
PFE:
-0.99
HOLX:
15.34%
PFE:
13.28%
HOLX:
23.27%
PFE:
23.84%
HOLX:
-93.75%
PFE:
-58.96%
HOLX:
-35.27%
PFE:
-56.84%
Fundamentals
HOLX:
$12.65B
PFE:
$130.59B
HOLX:
$2.38
PFE:
$1.38
HOLX:
23.84
PFE:
16.14
HOLX:
1.25
PFE:
0.58
HOLX:
3.14
PFE:
2.09
HOLX:
2.71
PFE:
1.43
HOLX:
$4.03B
PFE:
$62.46B
HOLX:
$2.08B
PFE:
$42.09B
HOLX:
$1.02B
PFE:
$16.71B
Returns By Period
In the year-to-date period, HOLX achieves a -21.28% return, which is significantly lower than PFE's -13.00% return. Over the past 10 years, HOLX has outperformed PFE with an annualized return of 5.25%, while PFE has yielded a comparatively lower 0.57% annualized return.
HOLX
-21.28%
-0.72%
-27.95%
-24.47%
1.45%
5.25%
PFE
-13.00%
5.16%
-13.62%
-15.14%
-4.98%
0.57%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HOLX vs. PFE — Risk-Adjusted Performance Rank
HOLX
PFE
HOLX vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Hologic, Inc. (HOLX) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
HOLX vs. PFE - Dividend Comparison
HOLX has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 7.63%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HOLX Hologic, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 7.63% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
Drawdowns
HOLX vs. PFE - Drawdown Comparison
The maximum HOLX drawdown since its inception was -93.75%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for HOLX and PFE. For additional features, visit the drawdowns tool.
Loading data...
Volatility
HOLX vs. PFE - Volatility Comparison
Hologic, Inc. (HOLX) has a higher volatility of 10.15% compared to Pfizer Inc. (PFE) at 9.05%. This indicates that HOLX's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
HOLX vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Hologic, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HOLX vs. PFE - Profitability Comparison
HOLX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Hologic, Inc. reported a gross profit of 382.00M and revenue of 1.01B. Therefore, the gross margin over that period was 38.0%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
HOLX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Hologic, Inc. reported an operating income of -7.00M and revenue of 1.01B, resulting in an operating margin of -0.7%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
HOLX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Hologic, Inc. reported a net income of -17.40M and revenue of 1.01B, resulting in a net margin of -1.7%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.